BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12809513)

  • 1. Identification of the putative MAP kinase docking site in the thyroid hormone receptor-beta1 DNA-binding domain: functional consequences of mutations at the docking site.
    Lin HY; Zhang S; West BL; Tang HY; Passaretti T; Davis FB; Davis PJ
    Biochemistry; 2003 Jun; 42(24):7571-9. PubMed ID: 12809513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation of nuclear hormone receptor superfamily members: thyroid hormone causes acetylation of its own receptor by a mitogen-activated protein kinase-dependent mechanism.
    Lin HY; Hopkins R; Cao HJ; Tang HY; Alexander C; Davis FB; Davis PJ
    Steroids; 2005; 70(5-7):444-9. PubMed ID: 15862828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase.
    Shih A; Lin HY; Davis FB; Davis PJ
    Biochemistry; 2001 Mar; 40(9):2870-8. PubMed ID: 11258898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR.
    Davis PJ; Shih A; Lin HY; Martino LJ; Davis FB
    J Biol Chem; 2000 Dec; 275(48):38032-9. PubMed ID: 10982791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-activated protein kinases potentiate thyroid hormone receptor transcriptional activity by stabilizing its protein.
    Chen SL; Chang YJ; Wu YH; Lin KH
    Endocrinology; 2003 Apr; 144(4):1407-19. PubMed ID: 12639924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional consequences of a MAPK docking site on human FcgammaRIIb.
    Medgyesi D; Sárközi R; Koncz G; Arató K; Váradi G; Tóth GK; Sármay G
    Immunol Lett; 2004 Mar; 92(1-2):83-90. PubMed ID: 15081531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function.
    Nascimento AS; Dias SM; Nunes FM; Aparício R; Ambrosio AL; Bleicher L; Figueira AC; Santos MA; de Oliveira Neto M; Fischer H; Togashi M; Craievich AF; Garratt RC; Baxter JD; Webb P; Polikarpov I
    J Mol Biol; 2006 Jul; 360(3):586-98. PubMed ID: 16781732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional studies of the Ssk1p response regulator protein of Candida albicans as determined by phenotypic analysis of receiver domain point mutants.
    Menon V; Li D; Chauhan N; Rajnarayanan R; Dubrovska A; West AH; Calderone R
    Mol Microbiol; 2006 Nov; 62(4):997-1013. PubMed ID: 17038117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human papillomavirus type 11 E1E4 protein is phosphorylated in genital epithelium.
    Bryan JT; Han A; Fife KH; Brown DR
    Virology; 2000 Mar; 268(2):430-9. PubMed ID: 10704351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low concentrations of bisphenol a suppress thyroid hormone receptor transcription through a nongenomic mechanism.
    Sheng ZG; Tang Y; Liu YX; Yuan Y; Zhao BQ; Chao XJ; Zhu BZ
    Toxicol Appl Pharmacol; 2012 Feb; 259(1):133-42. PubMed ID: 22227104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ETS-related transcription factor ERM is a nuclear target of signaling cascades involving MAPK and PKA.
    Janknecht R; Monté D; Baert JL; de Launoit Y
    Oncogene; 1996 Oct; 13(8):1745-54. PubMed ID: 8895521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif.
    Barsyte-Lovejoy D; Galanis A; Clancy A; Sharrocks AD
    Biochem J; 2004 Aug; 381(Pt 3):693-9. PubMed ID: 15132737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchical phosphorylation of the TNF-alpha receptor, TNF-R1, by p42Mapk/Erk at basic Pro-directed kinase sites.
    Van Linden AA; Cottin V; Frankel SK; Riches DW
    Biochemistry; 2005 May; 44(18):6980-9. PubMed ID: 15865443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of nongenomic actions of thyroid hormone.
    Davis PJ; Leonard JL; Davis FB
    Front Neuroendocrinol; 2008 May; 29(2):211-8. PubMed ID: 17983645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential targeting of the stress mitogen-activated protein kinases to the c-Jun dimerization protein 2.
    Katz S; Aronheim A
    Biochem J; 2002 Dec; 368(Pt 3):939-45. PubMed ID: 12225289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions.
    Biondi RM; Nebreda AR
    Biochem J; 2003 May; 372(Pt 1):1-13. PubMed ID: 12600273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
    Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rsk2 allosterically activates estrogen receptor alpha by docking to the hormone-binding domain.
    Clark DE; Poteet-Smith CE; Smith JA; Lannigan DA
    EMBO J; 2001 Jul; 20(13):3484-94. PubMed ID: 11432835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogen-activated protein kinases activate the nuclear localization sequence of human papillomavirus type 11 E1 DNA helicase to promote efficient nuclear import.
    Yu JH; Lin BY; Deng W; Broker TR; Chow LT
    J Virol; 2007 May; 81(10):5066-78. PubMed ID: 17344281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor.
    Tang HY; Lin HY; Zhang S; Davis FB; Davis PJ
    Endocrinology; 2004 Jul; 145(7):3265-72. PubMed ID: 15059947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.